26 February 2026
26 February 2026
This acquisition comes as GSK looks to stock up its pipeline amid the looming patent expiries soon to impact the company’s portfolio.
The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.
Vivtex is set to receive research funding, upfront payments, milestone payments up to $2.1bn, and tiered royalties.
The expanded offerings will allow IQVIA to serve a broader range of drug modalities and therapeutic areas.
Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.
The funding aligns with the in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody acquired from DartsBio Pharmaceuticals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
